Global Transdermal Patch Market Research Report 2023(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,800	142 Pages	Bosson Research	May, 2023	BOSS18165723

Best Price Guarantee
Price	from $2,800
Length	142 Pages
Publisher	Bosson Research
Published Date	May, 2023
SKU	BOSS18165723

Global Transdermal Patch Market Research Report 2023(Status and Outlook)

Report Overview

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

The Global Transdermal Patch Market Size was estimated at USD 6429.00 million in 2022 and is projected to reach USD 8234.96 million by 2029, exhibiting a CAGR of 3.60% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Transdermal Patch market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transdermal Patch Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transdermal Patch market in any manner.

Global Transdermal Patch Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grünenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Market Segmentation (by Type)

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Market Segmentation (by Application)

Residential

Commercial

Public Utilities

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Transdermal Patch Market

Overview of the regional outlook of the Transdermal Patch Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Transdermal Patch; 1.2 Key Market Segments; 1.2.1 Transdermal Patch Segment by Type; 1.2.2 Transdermal Patch Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Transdermal Patch Market Overview: 2.1 Global Market Overview; 2.1.1 Global Transdermal Patch Market Size (M USD) Estimates and Forecasts (2018-2029); 2.1.2 Global Transdermal Patch Sales Estimates and Forecasts (2018-2029); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Transdermal Patch Market Competitive Landscape: 3.1 Global Transdermal Patch Sales by Manufacturers (2018-2023); 3.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2018-2023); 3.3 Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.4 Global Transdermal Patch Average Price by Manufacturers (2018-2023); 3.5 Manufacturers Transdermal Patch Sales Sites, Area Served, Product Type; 3.6 Transdermal Patch Market Competitive Situation and Trends; 3.6.1 Transdermal Patch Market Concentration Rate; 3.6.2 Global 5 and 10 Largest Transdermal Patch Players Market Share by Revenue; 3.6.3 Mergers & Acquisitions, Expansion
4 Transdermal Patch Industry Chain Analysis: 4.1 Transdermal Patch Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Transdermal Patch Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 Industry Policies
6 Transdermal Patch Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Transdermal Patch Sales Market Share by Type (2018-2023); 6.3 Global Transdermal Patch Market Size Market Share by Type (2018-2023); 6.4 Global Transdermal Patch Price by Type (2018-2023)
7 Transdermal Patch Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Transdermal Patch Market Sales by Application (2018-2023); 7.3 Global Transdermal Patch Market Size (M USD) by Application (2018-2023); 7.4 Global Transdermal Patch Sales Growth Rate by Application (2018-2023)
8 Transdermal Patch Market Segmentation by Region: 8.1 Global Transdermal Patch Sales by Region; 8.1.1 Global Transdermal Patch Sales by Region; 8.1.2 Global Transdermal Patch Sales Market Share by Region; 8.2 North America; 8.2.1 North America Transdermal Patch Sales by Country; 8.2.2 U.S.; 8.2.3 Canada; 8.2.4 Mexico; 8.3 Europe; 8.3.1 Europe Transdermal Patch Sales by Country; 8.3.2 Germany; 8.3.3 France; 8.3.4 U.K.; 8.3.5 Italy; 8.3.6 Russia; 8.4 Asia Pacific; 8.4.1 Asia Pacific Transdermal Patch Sales by Region; 8.4.2 China; 8.4.3 Japan; 8.4.4 South Korea; 8.4.5 India; 8.4.6 Southeast Asia; 8.5 South America; 8.5.1 South America Transdermal Patch Sales by Country; 8.5.2 Brazil; 8.5.3 Argentina; 8.5.4 Columbia; 8.6 Middle East and Africa; 8.6.1 Middle East and Africa Transdermal Patch Sales by Region; 8.6.2 Saudi Arabia; 8.6.3 UAE; 8.6.4 Egypt; 8.6.5 Nigeria; 8.6.6 South Africa
9 Key Companies Profile: 9.1 Hisamitsu Pharmaceutical; 9.1.1 Hisamitsu Pharmaceutical Transdermal Patch Basic Information; 9.1.2 Hisamitsu Pharmaceutical Transdermal Patch Product Overview; 9.1.3 Hisamitsu Pharmaceutical Transdermal Patch Product Market Performance; 9.1.4 Hisamitsu Pharmaceutical Business Overview; 9.1.5 Hisamitsu Pharmaceutical Transdermal Patch SWOT Analysis; 9.1.6 Hisamitsu Pharmaceutical Recent Developments; 9.2 Johnson andamp; Johnson; 9.2.1 Johnson andamp; Johnson Transdermal Patch Basic Information; 9.2.2 Johnson andamp; Johnson Transdermal Patch Product Overview; 9.2.3 Johnson andamp; Johnson Transdermal Patch Product Market Performance; 9.2.4 Johnson andamp; Johnson Business Overview; 9.2.5 Johnson andamp; Johnson Transdermal Patch SWOT Analysis; 9.2.6 Johnson andamp; Johnson Recent Developments; 9.3 Novartis; 9.3.1 Novartis Transdermal Patch Basic Information; 9.3.2 Novartis Transdermal Patch Product Overview; 9.3.3 Novartis Transdermal Patch Product Market Performance; 9.3.4 Novartis Business Overview; 9.3.5 Novartis Transdermal Patch SWOT Analysis; 9.3.6 Novartis Recent Developments; 9.4 UCB Pharma; 9.4.1 UCB Pharma Transdermal Patch Basic Information; 9.4.2 UCB Pharma Transdermal Patch Product Overview; 9.4.3 UCB Pharma Transdermal Patch Product Market Performance; 9.4.4 UCB Pharma Business Overview; 9.4.5 UCB Pharma Transdermal Patch SWOT Analysis; 9.4.6 UCB Pharma Recent Developments; 9.5 Mylan; 9.5.1 Mylan Transdermal Patch Basic Information; 9.5.2 Mylan Transdermal Patch Product Overview; 9.5.3 Mylan Transdermal Patch Product Market Performance; 9.5.4 Mylan Business Overview; 9.5.5 Mylan Transdermal Patch SWOT Analysis; 9.5.6 Mylan Recent Developments; 9.6 Teva Pharmaceutical; 9.6.1 Teva Pharmaceutical Transdermal Patch Basic Information; 9.6.2 Teva Pharmaceutical Transdermal Patch Product Overview; 9.6.3 Teva Pharmaceutical Transdermal Patch Product Market Performance; 9.6.4 Teva Pharmaceutical Business Overview; 9.6.5 Teva Pharmaceutical Recent Developments; 9.7 Nitto Denko; 9.7.1 Nitto Denko Transdermal Patch Basic Information; 9.7.2 Nitto Denko Transdermal Patch Product Overview; 9.7.3 Nitto Denko Transdermal Patch Product Market Performance; 9.7.4 Nitto Denko Business Overview; 9.7.5 Nitto Denko Recent Developments; 9.8 Grünenthal; 9.8.1 Grünenthal Transdermal Patch Basic Information; 9.8.2 Grünenthal Transdermal Patch Product Overview; 9.8.3 Grünenthal Transdermal Patch Product Market Performance; 9.8.4 Grünenthal Business Overview; 9.8.5 Grünenthal Recent Developments; 9.9 IBSA Group; 9.9.1 IBSA Group Transdermal Patch Basic Information; 9.9.2 IBSA Group Transdermal Patch Product Overview; 9.9.3 IBSA Group Transdermal Patch Product Market Performance; 9.9.4 IBSA Group Business Overview; 9.9.5 IBSA Group Recent Developments; 9.10 GSK; 9.10.1 GSK Transdermal Patch Basic Information; 9.10.2 GSK Transdermal Patch Product Overview; 9.10.3 GSK Transdermal Patch Product Market Performance; 9.10.4 GSK Business Overview; 9.10.5 GSK Recent Developments; 9.11 Luye Pharma Group; 9.11.1 Luye Pharma Group Transdermal Patch Basic Information; 9.11.2 Luye Pharma Group Transdermal Patch Product Overview; 9.11.3 Luye Pharma Group Transdermal Patch Product Market Performance; 9.11.4 Luye Pharma Group Business Overview; 9.11.5 Luye Pharma Group Recent Developments; 9.12 Pfizer; 9.12.1 Pfizer Transdermal Patch Basic Information; 9.12.2 Pfizer Transdermal Patch Product Overview; 9.12.3 Pfizer Transdermal Patch Product Market Performance; 9.12.4 Pfizer Business Overview; 9.12.5 Pfizer Recent Developments; 9.13 Chattem; 9.13.1 Chattem Transdermal Patch Basic Information; 9.13.2 Chattem Transdermal Patch Product Overview; 9.13.3 Chattem Transdermal Patch Product Market Performance; 9.13.4 Chattem Business Overview; 9.13.5 Chattem Recent Developments; 9.14 Dr Reddy’s Laboratories; 9.14.1 Dr Reddy’s Laboratories Transdermal Patch Basic Information; 9.14.2 Dr Reddy’s Laboratories Transdermal Patch Product Overview; 9.14.3 Dr Reddy’s Laboratories Transdermal Patch Product Market Performance; 9.14.4 Dr Reddy’s Laboratories Business Overview; 9.14.5 Dr Reddy’s Laboratories Recent Developments; 9.15 Bayer; 9.15.1 Bayer Transdermal Patch Basic Information; 9.15.2 Bayer Transdermal Patch Product Overview; 9.15.3 Bayer Transdermal Patch Product Market Performance; 9.15.4 Bayer Business Overview; 9.15.5 Bayer Recent Developments; 9.16 Mundipharma; 9.16.1 Mundipharma Transdermal Patch Basic Information; 9.16.2 Mundipharma Transdermal Patch Product Overview; 9.16.3 Mundipharma Transdermal Patch Product Market Performance; 9.16.4 Mundipharma Business Overview; 9.16.5 Mundipharma Recent Developments; 9.17 Endo International; 9.17.1 Endo International Transdermal Patch Basic Information; 9.17.2 Endo International Transdermal Patch Product Overview; 9.17.3 Endo International Transdermal Patch Product Market Performance; 9.17.4 Endo International Business Overview; 9.17.5 Endo International Recent Developments; 9.18 Beijing Tide Pharmaceutical; 9.18.1 Beijing Tide Pharmaceutical Transdermal Patch Basic Information; 9.18.2 Beijing Tide Pharmaceutical Transdermal Patch Product Overview; 9.18.3 Beijing Tide Pharmaceutical Transdermal Patch Product Market Performance; 9.18.4 Beijing Tide Pharmaceutical Business Overview; 9.18.5 Beijing Tide Pharmaceutical Recent Developments
10 Transdermal Patch Market Forecast by Region: 10.1 Global Transdermal Patch Market Size Forecast; 10.2 Global Transdermal Patch Market Forecast by Region; 10.2.1 North America Market Size Forecast by Country; 10.2.2 Europe Transdermal Patch Market Size Forecast by Country; 10.2.3 Asia Pacific Transdermal Patch Market Size Forecast by Region; 10.2.4 South America Transdermal Patch Market Size Forecast by Country; 10.2.5 Middle East and Africa Forecasted Consumption of Transdermal Patch by Country
11 Forecast Market by Type and by Application (2024-2029): 11.1 Global Transdermal Patch Market Forecast by Type (2024-2029); 11.1.1 Global Forecasted Sales of Transdermal Patch by Type (2024-2029); 11.1.2 Global Transdermal Patch Market Size Forecast by Type (2024-2029); 11.1.3 Global Forecasted Price of Transdermal Patch by Type (2024-2029); 11.2 Global Transdermal Patch Market Forecast by Application (2024-2029); 11.2.1 Global Transdermal Patch Sales (K MT) Forecast by Application; 11.2.2 Global Transdermal Patch Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings